EGF and breast cancer: Overexpression of an isoform of NHS harbouring the SHD domain has been reported to inhibit the ability of MTLn3 breast cancer cells to respond to EGF by forming lamellipodia, whilst overexpression of an isoform of NHS without the SHD domain did not affect lamellipodia extension14.